MesencHyal-T is a biotechnology company that develops cellular medical therapies for the treatment of tissue regeneration.
MesencHyal-T has raised $250K in total funding. The most recent round was Pre-Seed. The last funding was announced in January 2024.
MesencHyal-T's investors include SF500.
MesencHyal-T is headquartered in Junin, Argentina.
MesencHyal-T is a biotechnology company that develops cellular medical therapies for the treatment of tissue regeneration.
MesencHyal-T is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MesencHyal-T — Funding & Investors." VCBacked, January 1, 2024, https://www.vcbacked.co/company/mesenchyal-t. Accessed August 14, 2026.
VCBacked. (2024). MesencHyal-T — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/mesenchyal-t
{{cite web |title=MesencHyal-T — Funding & Investors |url=https://www.vcbacked.co/company/mesenchyal-t |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated